Clinical trial
Efficacy and Safety of Levetiracetam in Prevention of Alcohol Relapse in Recently Detoxified Alcohol Dependent Patients
NCT00758277 is registered in ClinicalTrials.gov with Charite University, Berlin, Germany as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Levetiracetam in Prevention of Alcohol Relapse in Recently Detoxified Alcohol Dependent Patients
- Lead sponsor
- Charite University, Berlin, Germany
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2007
- Completion date
- December 31, 2009
- Enrollment
- 201 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
alcohol dependence, alcoholic relapse